Pharmaceutical Medicine

Preferences for Receiving Results from a Rare Disease Clinical Trial: A Survey of Subjects with Friedreich's Ataxia and their Parents

The European College of Neuropsychopharmacology (ECNP) Medicines Chest Initiative: Rationale and Promise

Structured Qualitative Benefit-Risk Assessment to Inform Go/No-Go Decisions for Phase III Testing of Pharmaceutical Products

Unregistered Medical Products Detected by Malaysia's Pharmacy Enforcement Division During Routine Inspection: A Cross-Sectional Study among Selected Mainstream Medicines' Retailers in the State of Sarawak

Untangling the Complexity of Funding Recommendations: A Comparative Analysis of Health Technology Assessment Outcomes in Four European Countries

US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)

Using Social Media Data in Routine Pharmacovigilance: A Pilot Study to Identify Safety Signals and Patient Perspectives

Variation in Liver Biochemistries in Patients with Decompensated Cirrhosis: Implications for Assessing Drug-Induced Liver Injury in Clinical Trials

Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?

The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore

Rule of Law and State Capacity: Keys to Market Access in Developing and Resource-Constrained Markets

Regulating Electronic Cigarettes: Not Tobacco and Not (Yet) Therapy